Latest Capital Raises News

NoviqTech Limited has secured a controlling stake in Coralia, an Australian biochar carbon removal company, positioning itself at the forefront of the rapidly expanding carbon dioxide removal market driven by data centre growth.

Powerhouse Ventures reports its inaugural operating cash flow positive quarter alongside strong fund performance and strategic fund launches, signalling a turning point for the investment house.

St Barbara Limited reports strong feasibility outcomes for its New Simberi Gold Project and Nova Scotia developments, backed by significant strategic investments and regulatory approvals.

TG Metals Limited has reported strong drilling results at its Van Uden Gold Project and maiden drilling success at Gold City, setting the stage for an updated Mineral Resource Estimate in early 2026.

Tinybeans Group’s acquisition of US-based Qeepsake fuels a sharp revenue jump and improved profitability in Q2 FY26, signalling early success in its growth strategy.

Siren Gold Limited has advanced its New Zealand gold and antimony projects with a major drilling campaign at Sams Creek and promising exploration results at Queen Charlotte, while navigating regulatory hurdles.

Arika Resources has reported significant extensions to gold mineralisation at its Yundamindra Gold Project in WA, alongside a successful $5.7 million capital raising and strategic asset sale.

Boab Metals has locked in over A$350 million in funding and made a Final Investment Decision to develop its Sorby Hills Silver-Lead-Zinc Project, moving swiftly towards first production in the second half of 2027.

Simble Solutions reported steady cash flow and operational growth in Q4 FY25, alongside a strategic acquisition and capital raise to bolster its energy intelligence offerings.

Tasman Resources reports a robust cash position and a valuable stake in Eden Innovations, while gearing up for significant drilling programs at its South Australian projects in 2026.

Element 25 Limited has made significant strides in advancing its Butcherbird Expansion Project in Western Australia, securing $60 million in funding and progressing key engineering and contract milestones. Simultaneously, the company moves closer to finalising financing for its US-based battery-grade manganese refinery.

Chimeric Therapeutics reports encouraging clinical progress in its CAR-T and NK cell therapy trials, alongside FDA orphan drug designation and a strategic funding boost to propel development.